Vitamin E supplementation increases circulating vitamin E metabolites tenfold in end-stage renal disease patients

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Lipids

• Publication date

  2003-08-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1007/s11745-003-1130-9PMID 14577659
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Peroxynitrite-induced oxidation of plasma lipids is enhanced in stable hemodialysis patients.

  2003cited by this paper
• Vitamin E activates gene expression via the pregnane X receptor.

  2003cited by this paper
• Tocopherol metabolites 2, 5, 7, 8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman (α-CEHC) and 2, 7, 8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman (γ-CEHC) in human serum after a single dose of natural vitamin E

  2002cited by this paper
• Accelerated atherosclerosis, dyslipidemia, and oxidative stress in end-stage renal disease

  2002cited by this paper
• Plasma F2-isoprostane levels are elevated in chronic hemodialysis patients.

  2002cited by this paper
• Oxidative stress in chronic renal failure as a cardiovascular risk factor.

  2002cited by this paper
• Gas chromatography mass spectrometry analysis of carboxyethyl-hydroxychroman metabolites of alpha- and gamma-tocopherol in human plasma.

  2002cited by this paper
• Effects of vitamin C and vitamin E on in vivo lipid peroxidation: results of a randomized controlled trial.

  2002cited by this paper
• Identities and differences in the metabolism of tocotrienols and tocopherols in HepG2 cells.

  2002cited by this paper
• Cytochrome P450 omega-hydroxylase pathway of tocopherol catabolism. Novel mechanism of regulation of vitamin E status.

  2002cited by this paper
• Evolution of Oxidative Stress and Inflammation During Hemodialysis and Their Contribution to Cardiovascular Disease

  2002cited by this paper
• α-tocopherol affects the urinary and biliary excretion of 2,7,8-trimethyl-2(2′-carboxyethyl)-6-hydroxychroman, γ-tocopherol metabolite, in rats

  2001cited by this paper
• Alpha-tocopherol affects the urinary and biliary excretion of 2,7,8-trimethyl-2 (2'-carboxyethyl)-6-hydroxychroman, gamma-tocopherol metabolite, in rats.

  2001cited by this paper
• Alpha- and gamma-tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine.

  2001cited by this paper
• Supplementation with vitamin E but not with vitamin C lowers lipid peroxidation in vivo in mildly hypercholesterolemic men

  2001cited by this paper
• Tocopherols are metabolized in HepG2 cells by side chain omega-oxidation and consecutive beta-oxidation.

  2001cited by this paper
• Failure to demonstrate a major anti-inflammatory effect with alpha tocopherol supplementation (400 IU/day) in normal subjects.

  2001cited by this paper
• IV. NKF-K/DOQI Clinical Practice Guidelines for Anemia of Chronic Kidney Disease: update 2000.

  2001cited by this paper
• Elevated plasma F2-isoprostanes in patients on long-term hemodialysis.

  2001cited by this paper
• α- and γ-tocotrienols are metabolized to carboxyethyl-hydroxychroman derivatives and excreted in human urine

  2001cited by this paper
• Tocopherols are metabolized in HepG2 cells by side chain ω-oxidation and consecutive β-oxidation

  2001cited by this paper
• Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy.

  2000cited by this paper
• gamma-tocopherol and its major metabolite, in contrast to alpha-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells.

  2000cited by this paper
• Occurrence and determination of a natriuretic hormone, 2,7,8-trimethyl-2-(beta-carboxyethyl)-6-hydroxy chroman, in rat plasma, urine, and bile.

  2000cited by this paper
• Cytochrome P4503A-dependent metabolism of tocopherols and inhibition by sesamin.

  2000cited by this paper
• Alpha tocopherol supplementation decreases serum C-reactive protein and monocyte interleukin-6 levels in normal volunteers and type 2 diabetic patients.

  2000cited by this paper
• γ-Tocopherol and its major metabolite, in contrast to α-tocopherol, inhibit cyclooxygenase activity in macrophages and epithelial cells

  2000cited by this paper
• Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial.

  2000cited by this paper
• Vitamin E alleviates the oxidative stress of erythropoietin in uremic children on hemodialysis

  2000cited by this paper
• A rapid method for the extraction and determination of vitamin E metabolites in human urine.

  2000cited by this paper
• Low-density lipoprotein postsecretory modification, monocyte function, and circulating adhesion molecules in type 2 diabetic patients with and without macrovascular complications: the effect of alpha-tocopherol supplementation.

  2000cited by this paper
• Low-Density Lipoprotein Postsecretory Modification, Monocyte Function, and Circulating Adhesion Molecules in Type 2 Diabetic Patients With and Without Macrovascular Complications The Effect of α-Tocopherol Supplementation

  2000cited by this paper
• Interaction between Nutrition and Inflammation in End-Stage Renal Disease

  2000cited by this paper
• Quantification of the alpha- and gamma-tocopherol metabolites 2,5,7, 8-tetramethyl-2-(2'-carboxyethyl)-6-hydroxychroman and 2,7, 8-trimethyl-2-(2'-carboxyethyl)-6-hydroxychroman in human serum.

  1999cited by this paper
• Quantification of the α- and γ-Tocopherol Metabolites 2,5,7,8-Tetramethyl-2-(2′-carboxyethyl)-6-hydroxychroman and 2,7,8-Trimethyl-2-(2′-carboxyethyl)-6-hydroxychroman in Human Serum

  1999cited by this paper
• Urinary excretion of 2,7, 8-trimethyl-2-(beta-carboxyethyl)-6-hydroxychroman is a major route of elimination of gamma-tocopherol in humans.

  1999cited by this paper
• Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure.

  1999cited by this paper
• Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation.

  1999cited by this paper
• Does vitamin C act as a pro‐oxidant under physiological conditions?

  1999cited by this paper
• Vitamin E: function and metabolism

  1999influential reference
• Dietary reference intakes: vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc.

  1998cited by this paper
• Erythropoietin and oxidative stress in haemodialysis: beneficial effects of vitamin E supplementation.

  1997cited by this paper
• Simultaneous determination of tissue tocopherols, tocotrienols, ubiquinols, and ubiquinones.

  1996cited by this paper
• Novel urinary metabolite of alpha-tocopherol, 2,5,7,8-tetramethyl-2(2'-carboxyethyl)-6-hydroxychroman, as an indicator of an adequate vitamin E supply?

  1995cited by this paper
• Measurement of antioxidants in human blood plasma.

  1994cited by this paper
• Preferential incorporation of alpha-tocopherol vs gamma-tocopherol in human lipoproteins.

  1989cited by this paper
• Discrepancies between serum and erythrocyte concentrations of vitamin E in hemodialysis patients: role of HDL-bound fraction of vitamin E.

  1988cited by this paper
• Serum half-life, distribution, hepatic uptake and biliary excretion of α-tocopherol in rats

  1987cited by this paper
• Serum half-life, distribution, hepatic uptake and biliary excretion of alpha-tocopherol in rats.

  1987cited by this paper
• Effects of large dose vitamin E supplementation on anemia in hemodialysis patients.

  1985cited by this paper
• A high-performance liquid chromatographic method for the determination of tocopherol in plasma and cellular elements of the blood.

  1979cited by this paper
• Interaction of swine lipoproteins with the low density lipoprotein receptor in human fibroblasts.

  1976cited by this paper

• Efficacy of vitamin E from dietary, circulation system, and supplementation on chronic obstructive pulmonary disease (COPD): a systematic review and meta-analysis.

  2025cites this paper
• Metabolism of natural forms of vitamin E and biological actions of vitamin E metabolites.

  2021cites this paper
• Gamma-tocopherol, a major form of vitamin E in diets: Insights into antioxidant and anti-inflammatory effects, mechanisms, and roles in disease management.

  2021cites this paper
• Cardiovascular and Metabolic Protection by Vitamin E: A Matter of Treatment Strategy?

  2020cites this paper
• Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence?

  2019cites this paper
• Strategies to decrease oxidative stress biomarker levels in human medical conditions: A meta-analysis on 8-iso-prostaglandin F2α

  2018cites this paper
• Oxidative stress in hemodialysis: Causative mechanisms, clinical implications, and possible therapeutic interventions

  2018cites this paper
• Kronik Böbrek Hastalığında Renal İnflamasyon ve Bazı Güncel Diyet Bileşenleri İlişkisi

  2018cites this paper
• The impact of fish oil and wheat germ oil combination on mineral-bone and inflammatory markers in maintenance hemodialysis patients: a randomized, double-blind, placebo-controlled clinical trial

  2017cites this paper
• Oxidative Stress in Hemodialysis Patients: A Review of the Literature

  2017cites this paper
• Systemic Redox Imbalance in Chronic Kidney Disease: A Systematic Review

  2016cites this paper
• Determination of Prooxidant and Antioxidant Balance, Clinical Parameters and Nutrient Intakes in Hemodialysis Patients

  2015cites this paper
• Associations of fish oil and vitamin B and E supplementation with cardiovascular outcomes and mortality in people receiving haemodialysis: a review

  2015cites this paper
• Is routine multivitamin supplementation necessary in US chronic adult hemodialysis patients? A systematic review.

  2015cites this paper
• Natural forms of vitamin E: metabolism, antioxidant, and anti-inflammatory activities and their role in disease prevention and therapy.

  2014influential citation
• Provision of antioxidant therapy in hemodialysis (PATH): a randomized clinical trial.

  2014cites this paper
• Vitamins in dialysis: who, when and how much?

  2014cites this paper
• Nondialyzable Uremic Toxins

  2013cites this paper
• The influence of vitamin E bonded haemodialysis membranes on erythropoiesis stimulating agent requirements, oxidative stress, inflammation, haemostasis and outcomes

  2013cites this paper
• Low plasma α-tocopherol concentrations and adverse clinical outcomes in diabetic hemodialysis patients.

  2013cites this paper
• Mechanisms for the prevention of vitamin E excess

  2013cites this paper
• Antioxidant therapy in hemodialysis patients: a systematic review.

  2012cites this paper
• Effects of vitamin E-coated membrane dialyser on markers of oxidative stress and inflammation in patients on chronic haemodialysis.

  2011cites this paper
• Effect of combined vitamins C and E supplementation on oxidant/antioxidant status in hemodialysis patients

  2010cites this paper
• Natural Antioxidants and Oxidative Stress Markers in Hemodialysis Patients

  2010cites this paper
• Increased monocyte adhesion-promoting capacity of plasma in end-stage renal disease - response to antioxidant therapy.

  2010cites this paper
• Antioxidant therapy does not ameliorate oxidative stress and inflammation in patients with end-stage renal disease.

  2009cites this paper
• A survey of supplementation practices in hemodialysis clinics

  2009cites this paper
• Effect of One‐year Oral α‐Tocopherol Administration on the Antioxidant Defense System in Hemodialysis Patients

  2008cites this paper
• F2-Isoprostanes in Human Health and Diseases: From Molecular Mechanisms to Clinical Implications

  2008cites this paper
• Serum vitamin E and oxidative protein modification in hemodialysis: a randomized clinical trial.

  2007cites this paper
• Gamma-tocopherol and docosahexaenoic acid decrease inflammation in dialysis patients.

  2007cites this paper
• Anti-inflammatory properties of aand c-tocopherol

  2007influential citation
• Vitamin E biotransformation in humans.

  2007cites this paper
• ["CLINICAL AND ANIMAL STUDIES OF LIPID-DERIVED PROTEIN MODIFICATIONS IN AUTISM, KIDNEY DIALYSIS, KERATITIS AND AGE-RELATED MACULAR DEGENERATION"]

  2007cites this paper
• Anti-inflammatory properties of alpha- and gamma-tocopherol.

  2007cites this paper
• Anti-inflammatory properties of a- and ?-tocopherol

  2007cites this paper
• CHAPTER 70 – Vitamin E and Vitamin K Metabolism

  2006cites this paper
• Einfluss der Matrix-Zusammensetzung von Vitamin E auf die Bioverfügbarkeit bei wachsenden Schweinen

  2006cites this paper
• Vitamin E in renal therapeutic regimens

  2006cites this paper
• Vitamin E and atherosclerosis: investigation of novel biological activities and metabolism of gamma-tocopherol in humans

  2006cites this paper
• C-reactive protein (CRP)-lowering agents.

  2006cites this paper
• The effect of gamma-tocopherol administration on alpha-tocopherol levels and metabolism in humans.

  2005cites this paper
• The effect of γ-tocopherol administration on α-tocopherol levels and metabolism in humans

  2005cites this paper
• Quantitation of rat liver vitamin E metabolites by LC-MS during high-dose vitamin E administration Published, JLR Papers in Press, February 16, 2005. DOI 10.1194/jlr.D400044-JLR200

  2005cites this paper
• Effect of 1-Year Oral α-Tocopherol Administration on Anticardiolipin Antibodies in Hemodialysis Patients

  2005cites this paper
• Alpha-tocopherol modulates Cyp3a expression, increases gamma-CEHC production, and limits tissue gamma-tocopherol accumulation in mice fed high gamma-tocopherol diets.

  2005cites this paper
• Vitamin E, oxidative stress, and inflammation.

  2005cites this paper
• Vitamins A, E and C as Non-Enzymatic Antioxidants and Their Relation to Lipid Peroxidation in Children with Chronic Renal Failure

  2005cites this paper
• Vitamin E regulation

  2005cites this paper
• α-Tocopherol modulates Cyp3a expression, increases γ-CEHC production, and limits tissue γ-tocopherol accumulation in mice fed high γ-tocopherol diets

  2005cites this paper
• Original Contribution a-Tocopherol modulates Cyp3a expression, increases g-CEHC production, and limits tissue g-tocopherol accumulation in mice fed high g-tocopherol diets

  2005cites this paper
• Anti‐inflammatory Effects of α‐Tocopherol

  2004cites this paper
• Inflammation and oxidative stress in ESRD--the role of myeloperoxidase.

  2004cites this paper
• Advances in diabetes for the millennium: vitamins and oxidant stress in diabetes and its complications.

  2004cites this paper
• Anti-inflammatory effects of alpha-tocopherol.

  2004cites this paper
• Vitamin E, nuclear receptors and xenobiotic metabolism.

  2004cites this paper
• Vitamin E in Uremia and Dialysis Patients

  2004cites this paper
• Geriatric Nephrology and Urology Literature

  2004cites this paper
• amma-Tocopherol and Docosahexaenoic cid Decrease Inflammation in ialysis Patients

  year unknowncites this paper